Professor Michael Pollastri is creating a new platform to share data with international researchers focused on neglected tropical diseases.
The secrecy model that dominates drug discovery doesn’t work for neglected tropical diseases. Associate Professor Michael Pollastri hopes to shift that paradigm with a new platform for secure data-sharing.
He has helped guide close to 200 students, postdoctoral researchers, and staff members, and now Dr. Barry Karger has been named to The Analytical Scientist’s POWER LIST.
Dr. Daniela Brunner of PsychoGenics talks at the Accelerating Translational Research for Drug Discovery conference at Northeastern University.
I first became interested in drugs to treat brain diseases with I was a pharmacy student at Northeastern in the early 1980s. After I got my PhD in medicinal chemistry at the University of California–San Francisco, I returned to Boston for a post-doctoral fellowship at Harvard Medical School. At the time, I was drawn to research on neurodegenerative diseases, such as Parkinson’s. But by 1987, I switched to neuropsychiatric diseases, and that’s what I’ve been focused on ever since.
Alternative energy sources are often touted as the solution to the waning global supply of oil and mounting evidence of carbon-induced climate change.
Northeastern is one of 20 U.S. universities committed to a greener way of doing and teaching chemistry.
With time, the amino acid known as asparagine will eventually degrade.
Rising senior Kaitlyn Duffy has explored a range of science and security-related topics.
Mehmet Ates and Matthew Trahan are working with research professor K. M. Abraham to develop the next generation of energy efficient lithium batteries.